BioScience Health Innovations Files 8-K

Ticker: BHIC · Form: 8-K · Filed: 2025-10-16T00:00:00.000Z

Sentiment: neutral

Topics: corporate-governance, filing-update

Related Tickers: BHIC

TL;DR

BHIC filed an 8-K for corporate governance updates and shareholder votes as of Sept 10, 2025.

AI Summary

BioScience Health Innovations, Inc. filed an 8-K on October 16, 2025, reporting events as of September 10, 2025. The filing primarily concerns amendments to its Articles of Incorporation or Bylaws, submission of matters to a vote of security holders, and financial statements and exhibits. The company, formerly known as Nowtransit Inc., is incorporated in Nevada and has its principal executive offices in Salt Lake City, UT.

Why It Matters

This 8-K filing indicates significant corporate actions, including potential changes to the company's governing documents and shareholder votes, which could impact the company's structure and future direction.

Risk Assessment

Risk Level: low — The filing is a routine corporate disclosure and does not appear to contain immediate negative financial or operational news.

Key Players & Entities

FAQ

What specific amendments were made to the Articles of Incorporation or Bylaws?

The filing indicates that amendments were made, but the specific details of these amendments are not provided in the excerpt. Further review of the attached exhibits would be necessary.

What matters were submitted to a vote of security holders?

The filing states that matters were submitted to a vote of security holders, but the nature of these matters is not detailed in the provided text. The exhibits would contain this information.

What financial statements and exhibits are included with this filing?

The filing lists 'Financial Statements and Exhibits' as an item information, indicating their inclusion, but the specific content of these exhibits is not detailed in the excerpt.

When was BioScience Health Innovations, Inc. formerly known as Nowtransit Inc.?

The company's name was changed from Nowtransit Inc. on August 2, 2019.

What is the principal business address of BioScience Health Innovations, Inc.?

The principal executive offices are located at 2722 S West Temple, Salt Lake City, UT 84115.

From the Filing

0001185185-25-001456.txt : 20251016 0001185185-25-001456.hdr.sgml : 20251016 20251016154705 ACCESSION NUMBER: 0001185185-25-001456 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 18 CONFORMED PERIOD OF REPORT: 20250910 ITEM INFORMATION: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year ITEM INFORMATION: Submission of Matters to a Vote of Security Holders ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20251016 DATE AS OF CHANGE: 20251016 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BioScience Health Innovations, Inc. CENTRAL INDEX KEY: 0001784440 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374] ORGANIZATION NAME: 06 Technology EIN: 000000000 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-234487 FILM NUMBER: 251397567 BUSINESS ADDRESS: STREET 1: 2722 S WEST TEMPLE CITY: SALT LAKE CITY STATE: UT ZIP: 84115 BUSINESS PHONE: 801-949-0791 MAIL ADDRESS: STREET 1: 2722 S WEST TEMPLE CITY: SALT LAKE CITY STATE: UT ZIP: 84115 FORMER COMPANY: FORMER CONFORMED NAME: Nowtransit Inc DATE OF NAME CHANGE: 20190802 8-K 1 bhic8k101625.htm FORM 8-K false --12-31 0001784440 0001784440 2025-09-10 2025-09-10 iso4217:USD xbrli:shares iso4217:USD xbrli:shares     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549       FORM 8-K       CURRENT REPORT   Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934   Date of Report (Date of earliest event reported): September 10, 2025   BioScience Health Innovations, Inc. (Exact name of registrant as specified in its charter)   Nevada   333-234487   98-1498782 (State of Incorporation)   (Commission File Number)   (IRS Employer ID No.)   2722 S West Temple Salt Lake City , UT 84115 (Address of Principal Executive Offices)   ( 801 ) 949-0791 (Registrant's Telephone Number including Area Code)   NOWTRANSIT INC. (Former name or address, if changed since last report)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities registered pursuant to Section 12(b) of the Act: None   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company ☒   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒             SECTION 5. CORPORATE GOVERNANCE AND MANAGEMENT   Item 5.03 Amendments to Articles of Incorporation or Bylaws   On September 10, 2025, BioScience Health Innovations, Inc. (the “Company”) amended its Restated Certificate of Incorporation (the “Certificate of Incorporation”), to effect a reverse split of the Company’s common stock on the basis that 4 (four) such shares of common stock shall become 1 (one) share of common stock. The Reverse Split became effective on September 10, 2025.   The Board of Directors of the Company (the “Board”) approved the Reverse Split

View on Read The Filing